KENNETH LUCERO: Open Payments
NPI 1417079989 · BLYTHE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$178 in 8 payments from 5 companies in 2025. Trend: 2023 $143 · 2024 $221 · 2025 $178
Food & beverage: $178
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $85 |
| Vanda Pharmaceuticals Inc. | 1 | $34 |
| Lilly USA, LLC | 1 | $23 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| Lundbeck LLC | 1 | $17 |
Products named: REXULTI, HETLIOZ, MOUNJARO, VERQUVO.
Industry payments across CA — which companies pay providers there.
